Managing Director, MSL UK & EMEA (Healthcare)
Avril had over 20 years’ experience in healthcare communications working internationally and in the UK, reaching out to both healthcare professionals and the public. Avril has directed communications programmes across the product lifecycle from Phase II to end of patent, working on both innovative treatment advances and well established medicines. As part of this work, she has considerable experience of managing international clinical trial announcements working with companies such as Roche, on high profile drugs such as Herceptin, Avastin and Fuzeon, as well as Bayer, Astra Zeneca and GSK. Milestone trial announcements have include a variety of opportunities from new molecule ‘proof of concept’ to addressing new indications to redefining treatment approaches. Avril has worked extensively in the areas of stakeholder management, media strategy, message development, issues preparedness, disease awareness campaigns and social media outreach. She has worked on many complex therapies including several classes of biologics and has expertise in making high science accessible to patients and their families - 'high tech to the high street'. Avril’s therapeutic experience covers areas such as oncology, CDV, diabetes, immune-mediated inflammatory disease (Psoriasis, Crohn’s disease, RA), gastroenterology, respiratory, anti-infectives, women’s health and CNS (Parkinson’s disease and epilepsy). Avril studied Biochemistry at the University of London and later completed a diploma in Film Studies.